Open AccessMultiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer
Author(s) -
Turkbey Baris,
Brown Anna M.,
Sankineni Sandeep,
Wood Bradford J.,
Pinto Peter A.,
Choyke Peter L.
Publication year - 2015
Publication title -
ca: a cancer journal for clinicians
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 62.937
H-Index - 168
eISSN - 1542-4863
pISSN - 0007-9235
DOI - 10.3322/caac.21333
Subject(s) - prostate cancer , medicine , prostate , magnetic resonance imaging , cancer , biopsy , radiology , oncology
Imaging has traditionally played a minor role in the diagnosis and staging of prostate cancer. However, recent controversies generated by the use of prostate‐specific antigen (PSA) screening followed by random biopsy have encouraged the development of new imaging methods for prostate cancer. Multiparametric magnetic resonance imaging (mpMRI) has emerged as the imaging method best able to detect clinically significant prostate cancers and to guide biopsies. Here, the authors explain what mpMRI is and how it is used clinically, especially with regard to high‐risk populations, and we discuss the impact of mpMRI on treatment decisions for men with prostate cancer. CA Cancer J Clin 2016;66:326‐336. © 2015 American Cancer Society